期刊文献+

N末端脑钠肽对急性呼吸困难病因诊断的价值 被引量:7

Nt-proBNP in etiological diagnosis of acute dyspnea
下载PDF
导出
摘要 目的探讨N-末端脑钠肽(Nt-ProBNP)在鉴别心源性和非心源性呼吸困难的临床价值,特别是鉴别舒张性心力衰竭(DHF)与慢性阻塞肺疾病(COPD)的价值。方法比较分析明确诊断的96例急性呼吸困难患者中心源性呼吸困难患者(56例)和非心源性呼吸困难患者(40例)的Nt-ProBNP水平,同时对25例DHF和28例COPD急性发作期的Nt-ProBNP、心脏彩超的左室射血分数(LVEF)、二尖瓣舒张早晚期流速峰值比(E/A)、E峰减速时间(DT),收缩期肺动脉压(SPAP)、肺功能(FEV1)进行分析比较。结果心源性呼吸困难患者Nt-ProBNP水平明显高于非心源性呼吸困难组[(4121.05±3326.24)pg/mlvs(729.16±524.06)pg/ml,P<0.01];DHF患者Nt-ProBNP水平明显高于COPD亚组[(3853.97±2125.05)pg/mlvs(514.67±428)pg/ml,P<0.01]。结论测Nt-ProBNP简便、快捷,可作为鉴别急性呼吸困难患者有临床价值的观察指标。特别对老年多发的、常见的、临床又难以判断的COPD与DHF的诊断有一定指导意义。 Objective To explore N-terminal Pro-BNP (Nt-proBNP) in the differential diagnosis of cardiogenic and non-cardiogenic dyspnea,especially in diastolic heart failure (DHF) and chronic obstructive pulmonary disease (COPD).Methods Ninety-six cases were divided into two groups (56 cases of cardiogenic dyspnea and 40 cases of non-cardiogenic dyspnea) and comparatively analyzed,including 25 cases of DHF and 28 cases of COPD.Nt-proBNP,left ventricular ejection fraction (LVEF) by echocardiography,the ratio of peak early filling velocity to late filling velocity (E/A),E wave deceleration time(DTE),systolic pulmonary artery pressure (SPAP) and forced expiratory volume in one second (FEV1) of the above 25 cases of DHF and 28 cases of COPD in acute episode were comparatively analyzed.Results Nt-proBNP in cardiogenic dyspnea patients was significantly higher than that in non-cardiogenic dyspnea patients [(4121.05±3326.24) pg/ml vs (729.16±524.06) pg/ml,P0.01],while Nt-proBNP in DHT patients was significantly higher than that in COPD patients [(3853.97±2125.05) pg/ml vs (514.67±428) pg/ml,P0.01].Conclusion This study shows that Nt-proBNP could be used as an observation criterion of the differential diagnosis of dyspnea for its convenience and fast efficacy,especially used in the differential diagnosis of DHF and COPD of the aged.
出处 《实用医院临床杂志》 2010年第6期63-65,共3页 Practical Journal of Clinical Medicine
关键词 呼吸困难 N-末端脑钠肽 诊断 Dyspnea N-terminal pro-BNP Diagnosis
  • 相关文献

参考文献11

  • 1Januzzi JL,camargo CA,Anwaruddin S,et al..The N-terminal pro-BNP investigatlon of dyspnea in the emergency department(PRIDE)stuty[J].Am J cardlol,2005,95(8):948-954.
  • 2Yturralde RF,Gaasch WH.Diagnostic criteria for diastolic heart faiture[J].Prog Cardiovasec Dis,2005,47(5):314-319.
  • 3中华医学会呼吸病学分会.慢性阻塞性肺疾病(COPD)诊治规范[J].中华结核和呼吸杂志,1997,20:99-106.
  • 4Sudoh T,Kangawa K,Minamino N,et al..A new natriuretic peptide in porcine brain[J].Nature,1988,332(6159):78-81.
  • 5Mueller T,Gegenhuber A,Poelz W,et al..Diagnostic accuracy Of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart faiturc[J].Heart,2005,91(5):606-612.
  • 6Maisel AS,Krishnaswamy P,Nowak RM,et al..Rapid measurement of B-type Natriuretic peptide in the emergency diagnosis of beart failure[J].N Engl J Med,2002,347(1):161-167.
  • 7Cabancs L,Richaud-Thincs B,Fulla Y,et al..Brain natriuretic peptid blood levels in the differential diagnosis of dyspnea[J].Chest,2001,120(19):2047-2050.
  • 8巫文丽,廖雪松,王伟,燕纯伯,蔡琳,王引利,何川,唐炯,刘汉雄,邓晓奇.BNP与有创血流动力学指标的相关性分析[J].四川医学,2008,29(7):838-839. 被引量:7
  • 9Nagaya N,Nishikimi T,Uematsu M,et al..Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension[J].Circulation,2000,102(8):865-870.
  • 10张继伟.低分子肝素对慢性心力衰竭伴肾功能不全患者血肌酐及脑钠肽的影响[J].实用医院临床杂志,2008,5(6):59-60. 被引量:1

二级参考文献15

  • 1王家宏,黄永麟.脑钠肽在心力衰竭诊治中的应用进展[J].中国实用内科杂志,2005,25(7):657-658. 被引量:21
  • 2[1]Betteneourt P,Ferreim A,Dias P,et al.Evaluation of brain natriuretic peptide in the diagnosis of heart failure[J].Candiology,2000,93(1):19-25.
  • 3[2]Koglin J,Pehlivali S,Schwaiblmair M,et al.Role of brain natriuretic in risk stratification of patients with congestive heart failure[J].J Am Coil Cardiol,2001,38(7):1934-1941.
  • 4[3]Mottram PM,Leano B,Marwick TH.Usefulness of B.type B-type natiuretic peptide in hypertensive patients with exertional dyspnea and nomud left ventrieular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function[J].Am J Caidiol,2003,92(12):1434-1438.
  • 5[4]Vasan RS,Benjamin FJ,Larson MG,et al.Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction:the Framingham heart study[J].JAMA,2002,288(10):1252-1259.
  • 6[5]Adama V,Jiang H,Yu JT,et al.Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance[J].J Am Coil Cardiol,1999,33(8):959-965.
  • 7[6]Wang TJ,Larson MG,kvy D,et al.Plasma natriuretic peptides levels and the risk of cardiovascular events and death[J].N Eng J Med,2004,350(5):655-663.
  • 8黄彦生 魏经汉 魏太星 等.脑钠素和N-心钠素对无症状性心力衰竭的诊断价值.中华心血管病杂志,1998,26(3):231-231.
  • 9陈灏珠.实用内科学[M] 第11版[M].北京:人民卫生出版社,2001.2104-2105.
  • 10Mukoyama M,Nakao K,Saita Y,et al.Increased human brain natriuretic peptide in congestive heart failure[J].N Engl J Med,1990:757-758.

共引文献106

同被引文献48

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部